Target intelligence / Profile preview

Hook-associated protein 2 (HAP2) (HAP2)

Target
HAP2
Molecular classification
Class II membrane fusion protein, Fusogen, Membrane protein
01

Overview

Hook-associated protein 2 (HAP2), also known as Generative cell-specific protein 1 (GCS1), is a highly conserved membrane protein essential for gamete fusion across diverse eukaryotic lineages, including plants, protists, and invertebrates (UniProt Q8I4V7). In the context of human health, HAP2 is a primary target for transmission-blocking vaccines (TBVs) against malaria-causing parasites like Plasmodium falciparum (Angrisano et al., 2017, BMC Biology). Structurally, HAP2 is classified as a Class II viral-like fusogen, sharing significant homology with fusion proteins found in viruses such as Dengue and Zika (Fedry et al., 2017, Cell). It is specifically expressed on the surface of male gametes, where it facilitates the merger of the male and female plasma membranes during fertilization in the mosquito midgut (Pinello et al., 2017, JBC). Therapeutic strategies focus on inducing antibodies that bind to the extracellular domain of HAP2, thereby neutralizing the parasite's ability to reproduce sexually and preventing the spread of infection to new hosts. Because HAP2 is absent in mammals, it represents a highly specific target with a low risk of off-target effects in humans.

Other names
Generative cell-specific protein 1GCS1HAP2/GCS1HAP2 homologue
02

Mechanism of action

Inhibition of gamete fusion by binding to the extracellular domain of HAP2 on male gametes, preventing the merger of male and female plasma membranes during the sexual stage of the parasite life cycle (Fedry et al., 2017, Cell).

03

Biological functions

Gamete fusionFertilizationMembrane fusionSexual reproduction
04

Disease associations

MalariaInfection
05

Safety considerations

Low natural immunogenicity requiring potent adjuvantsPotential for antigenic variation among different parasite strainsLimited clinical safety data for HAP2-specific vaccine platforms
06

Interacting drugs

PfHAP2 vaccine (experimental)

2 more in the full profile.

07

Biomarkers

Anti-HAP2 antibody titersStandard Membrane Feeding Assay (SMFA) activity

Beyond the preview

Go deeper on Hook-associated protein 2 (HAP2) (HAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hook-associated protein 2 (HAP2) (HAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call